Fertility and sterility, 2017
Committee members: Judith Daar, Jean Benward, Lee Collins, Joseph Davis, Leslie Francis, Elena Gates, Elizabeth Ginsburg, Sigal Klipstein, Barbara Koenig, Andrew La Barbera, Laurence McCullough, Richard Reindollar, Mark Sauer, Rebecca Sokol, Sean Tipton, Lynn Westphal
RRM Academy Synopsis
“in circumstances in which a child is highly likely to be born with a life-threatening condition that causes severe and early debility with no possibility of reasonable function, provider transfer of such embryos is ethically problematic and highly discouraged.”
Quoted verbatim from this paper.
Patient requests for transfer of embryos with genetic anomalies linked to serious health-affecting disorders detected in preimplantation testing are rare but do exist. This Opinion sets out the possible rationales for a provider's decision to assist or decline to assist in such transfers. The Committee concludes in most clinical cases it is ethically permissible to assist or decline to assist in transferring such embryos. In circumstances in which a child is highly likely to be born with a life-threatening condition that causes severe and early debility with no possibility of reasonable function, provider transfer of such embryos is ethically problematic and highly discouraged.
Ethics Committee of the American Society for Reproductive Medicine (2017). Transferring embryos with genetic anomalies detected in preimplantation testing: an Ethics Committee Opinion. Fertility and sterility. https://doi.org/10.1016/j.fertnstert.2017.02.121
Ethics Committee of the American Society for Reproductive Medicine. Transferring embryos with genetic anomalies detected in preimplantation testing: an Ethics Committee Opinion. Fertility and sterility. 2017. doi:10.1016/j.fertnstert.2017.02.121
Ethics Committee of the American Society for Reproductive Medicine. "Transferring embryos with genetic anomalies detected in preimplantation testing: an Ethics Committee Opinion." Fertility and sterility, 2017.